...
首页> 外文期刊>World Journal of Gastroenterology >NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China
【24h】

NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China

机译:华北地区NQO1 C609T基因多态性与食管癌和胃cardiac门癌相关

获取原文
获取原文并翻译 | 示例

摘要

AIM: To investigate the association of the NQO1 (C609T) polymorphism with susceptibility to esophageal squamous cell carcinoma (ESCC) and gastric cardiac adenocarcinoma (GCA) in North China. METHODS: The NQO1 C609T genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 317 cancer patients (193 ESCC and 124 GCA) and 165 unrelated healthy controls. RESULTS: The NQO1 C609T C/C, C/T and T/T genotype frequency among healthy controls was 31.5 %, 52.1 % and 16.4 % respectively. The NQO1 T/T genotype frequency among ESCC patients (25.9 %) was significantly higher than that among healthy controls (Χ~2=4.79, P=0.028). The NQO1 T/T genotype significantly increased the risk for developing ESCC compared with the combination of C/C and C/T genotypes, with an age, sex and smoking status adjusted odds ratio (OR) of 1.78 (1.04-2.98). This increased susceptibility was pronounced in ESCC patients with family histories of upper gastrointestinal cancers (UGIC) (adjusted OR=2.20, 95 % CI=1.18-3.98). Similarly, the susceptibility of the NQO1T/T genotype to GCA development was also observed among patients with family histories of UGIC, with an adjusted odds ratio of 2.55 (95 % CI=1.21-5.23), whereas no difference in NQO1 genotype distribution was shown among patients without family histories of UGIC. CONCLUSION: Determination of the NQO1 C609T genotype may be used as a stratification marker to predicate the individuals at high risk for developing ESCC and GCA in North China.
机译:目的:探讨华北地区NQO1(C609T)基因多态性与食管鳞状细胞癌(ESCC)和胃cardiac门腺癌(GCA)易感性的关系。方法:采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析法确定了317例癌症患者(193例ESCC和124例GCA)和165例无关健康对照者的NQO1 C609T基因型。结果:健康对照组中NQO1 C609T C / C,C / T和T / T基因型频率分别为31.5%,52.1%和16.4%。 ESCC患者中NQO1 T / T基因型频率(25.9%)显着高于健康对照者(Χ〜2 = 4.79,P = 0.028)。与C / C和C / T基因型的组合相比,NQO1 T / T基因型显着增加了发展ESCC的风险,其年龄,性别和吸烟状况调整后的优势比(OR)为1.78(1.04-2.98)。具有家族史的上消化道癌(UGIC)的ESCC患者明显增加了这种敏感性(校正OR = 2.20,95%CI = 1.18-3.98)。同样,在有UGIC家族病史的患者中也观察到NQO1T / T基因型对GCA的易感性,调整后的优势比为2.55(95%CI = 1.21-5.23),而NQO1基因型分布没有差异没有UGIC家族史的患者中。结论:NQO1 C609T基因型的确定可作为分层标记,以预测华北地区发生ESCC和GCA的高风险人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号